COVID - Janssen

Service Description

Johnson & Johnson’s Janssen COVID-19 vaccine is a single dose vaccine for the prevention of coronavirus caused by severe acute respiratory syndrome. With an EUA approved for individuals 18 years of age and older, the vaccine has a 66.3% efficacy in severe diseases.